Alcon News
Most Popular Alcon Story
Novartis pledges $39B for Alcon
In a bid to diversify its business away from traditional pharma, Novartis has bought a 25 percent stake in Alcon and is eyeing the purchase of another 52 percent in 2010. The Swiss drugmaker paid... Read more...
Latest Headlines
- July 8, 2008
- May 20, 2008
- April 15, 2008
- April 14, 2008
- April 9, 2008
- April 8, 2008
- April 7, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
